
| Asbestos Mesothelioma Lung Cancer Guide - Get advice on asbestos and mesothelioma help, symptoms, treatment exposure, legal options like lawyers, attorney & lawsuits. |
![]() |
|
|
Home :: Cancer Medicines and Drugs ::
Epirubicin
EPIRUBICIN HydrochlorideEpirubicin is a new anthracycline antibiotic with antiblastic activity. The mechanism of action of it is related to its ability to bind to DNA. Cell culture studies have shown rapid cell penetration, localisation in the nucleus and inhibition of nucleic acid synthesis and mitosis. Indications of Epirubicin
Dosage of Epirubicin60-90 mg/m2 body area; the drug should be Injected i.v. over 3-5 minutes and depending on' the patient's haematomedullar status, the dose should be repeated at 21-day intervals. Lower doses (60-75 mg/m2) are recommended for patients whose bone marrow function has already been impaired by previous chemotherapy or radiotherapy, by age or neoplastic bone-marrow infiltration. The total dose per cycle may be divided over 2-3 successive days. When the drug is used in combination with other antitumour agents, the doses need to be adequately reduced. Contra-indications of Epirubicin
Special Precautions of EpirubicinWhite and red blood cells and platelet counts should be carefully monitored. Cardiac function must be carefully monitored. Pregnancy. Side-effects of Epirubicin
Epirubicin -- Directions for administrationEpirubicin rapid dissolution should be administered by intravenous injection. Epirubicin is not active when given orally and should not be injected intramuscularly or intrathecally. Epirubicin should not be mixed with heparin due to chemical incompatibility. Epirubicin can be used in combination with other antitumour agents, but it is not recommended that it is mixed with these drugs in the same syringe.
|
||||||||||||||||||